Your browser doesn't support javascript.
loading
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice.
Fusar-Poli, Paolo; Manchia, Mirko; Koutsouleris, Nikolaos; Leslie, David; Woopen, Christiane; Calkins, Monica E; Dunn, Michael; Tourneau, Christophe Le; Mannikko, Miia; Mollema, Tineke; Oliver, Dominic; Rietschel, Marcella; Reininghaus, Eva Z; Squassina, Alessio; Valmaggia, Lucia; Kessing, Lars Vedel; Vieta, Eduard; Correll, Christoph U; Arango, Celso; Andreassen, Ole A.
Afiliación
  • Fusar-Poli P; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; South London and Maudsley NHS Foundation Trust, London, UK; Department of Brain and Behavioral Sciences, Unive
  • Manchia M; Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; Unit of Clinical Psychiatry, University Hospital Agency of Cagliari, Cagliari, Italy; Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Koutsouleris N; Section for Neurodiagnostic Applications, Ludwig-Maximilian-University, Munich.
  • Leslie D; Ethics Theme Lead, The Alan Turing Institute.
  • Woopen C; Center for Life Ethics, University of Bonn.
  • Calkins ME; Neurodevelopment and Psychosis Section and Lifespan Brain Institute of Penn/CHOP, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, USA.
  • Dunn M; Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore.
  • Tourneau CL; Institut Curie, Department of Drug Development and Innovation (D3i), INSERM U900 Research unit, Paris-Saclay University, France.
  • Mannikko M; European Federation of Associations of Families of People with Mental Illness (EUFAMI), Leuven, Belgium.
  • Mollema T; Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN), Brussels, Belgium.
  • Oliver D; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Rietschel M; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Reininghaus EZ; Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
  • Squassina A; Section of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Italy.
  • Valmaggia L; South London and Maudsley NHS Foundation Trust, London, UK; Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Department of Psychiatry, KU Leuven, Belgium.
  • Kessing LV; Copenhagen Affective disorder Research Center (CADIC), Psychiatric Center Copenhagen, Denmark; Department of clinical Medicine, University of Copenhagen, Denmark.
  • Vieta E; Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Correll CU; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Center for Psychiatric Neuroscience; The Feinstein Institutes for Medi
  • Arango C; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Gregorio Marañón; Health Research Institute (IiGSM), School of Medicine, Universidad Complutense de Madrid; Biomedical Research Center for Mental Health (CIBERSA
  • Andreassen OA; NORMENT, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Eur Neuropsychopharmacol ; 63: 17-34, 2022 10.
Article en En | MEDLINE | ID: mdl-36041245

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psiquiatría / Trastornos Mentales Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: Eur Neuropsychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psiquiatría / Trastornos Mentales Tipo de estudio: Diagnostic_studies / Prognostic_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: Eur Neuropsychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos